LGALS9 and breast carcinoma: Additionally, NK cells interacting with galectin-9 on the breast cancer cell surface may release interferon gamma (IFN-γ) in response (2, 35) which could activate cytotoxic lymphoid cells located in the area of the tumor microenvironment.